Fosinopril Sodium and Hydrochlorothiazide - Fosinopril Sodium and Hydrocholorothiazide
Navigation: NDC > Supplier starting with: R > RANBAXY PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 63304-403 |
| Proprietary Name: | Fosinopril Sodium and Hydrochlorothiazide |
| Suffix: | |
| Non-Proprietary Name: | Fosinopril Sodium and Hydrocholorothiazide |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 20-12-2004 |
| Category Name: | ANDA |
| Application Number: | ANDA076739 |
| Labeler: | RANBAXY PHARMACEUTICALS INC. |
| Substance Name: | FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE |
| Active Numerator Strength: | 10; 12.5 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |